| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
12,300 |
9,219 |
$1.53M |
| 11721 |
|
1,222 |
1,109 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
507 |
340 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
309 |
228 |
$0.00 |
| 11056 |
|
1,641 |
1,155 |
$0.00 |
| 11719 |
|
2,957 |
2,273 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
716 |
302 |
$0.00 |
| 11720 |
|
366 |
277 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
12 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,125 |
6,468 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,979 |
1,745 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
192 |
150 |
$0.00 |
| 87081 |
|
69 |
51 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
297 |
256 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
252 |
206 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
600 |
474 |
$0.00 |
| 11055 |
|
21 |
12 |
$0.00 |
| 85018 |
|
25 |
13 |
$0.00 |